Casey Woodring
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
27
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintains: Overweight | $375 → $280 | $220.40 | +27.04% | 4 | Oct 25, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | $270 → $205 | $180.96 | +13.28% | 5 | Aug 8, 2024 | |
| HOLX Hologic | Maintains: Overweight | $91 → $95 | $82.33 | +15.39% | 4 | Jul 30, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $52 → $54 | $43.08 | +25.35% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $4.17 | +43.88% | 3 | May 13, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $39.10 | -5.37% | 3 | Feb 14, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $26.09 | -11.84% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $15.86 | +13.49% | 2 | Jan 23, 2023 |
ICON Public Limited Company
Oct 25, 2024
Maintains: Overweight
Price Target: $375 → $280
Current: $220.40
Upside: +27.04%
Charles River Laboratories International
Aug 8, 2024
Downgrades: Neutral
Price Target: $270 → $205
Current: $180.96
Upside: +13.28%
Hologic
Jul 30, 2024
Maintains: Overweight
Price Target: $91 → $95
Current: $82.33
Upside: +15.39%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $43.08
Upside: +25.35%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $4.17
Upside: +43.88%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $39.10
Upside: -5.37%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $26.09
Upside: -11.84%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $15.86
Upside: +13.49%